PDCD1LG2 and brain neoplasm: Finally, we investigated the effects of this treatment strategy on the expression of PD-L1 and PD-L2 in myeloid cells and found an increase in the percentage of myeloid cells expressing PD-L1 in the brain tumor, lymph node, and spleen.